Up next
Share article
The post has been shared by 0 people.
Mail 0
LinkedIn 0
Twitter 0

Podcast 37: Incorporating Sustainability into the Bio/Pharma Supply Chain: Where Does the Industry Stand?

A newly released DCAT benchmarking study examines the targets and progress made by bio/pharma companies and suppliers in reaching their sustainability goals.

Key topics: (see Chapter Markers in drop down menu in audio player above)

  • Sustainability and the bio/pharma supply chain (1:14)
  • Key finding: External stakeholders drive efforts (3:43)
  • Key finding: Supply-chain sustainability lags internal efforts (5:05)
  • Key finding: Measuring achievement a major challenge (8:58)
  • Key finding:  Factoring sustainability into purchasing decisions (10:39)
    Concluding thoughts (12:02)

Sponsor: LGM Pharma

Links:

You May Also Like

Podcast 44: What’s Trending: Parenteral Drug Development & Manufacturing

What are some key trends and issues arising in parenteral drug development and manufacturing? From more complex molecules and modalities and sterile drug-product capacity market shifts, DCAT Value Chain Insights…

Podcast 43: CDMOs/CMOs: The Movers and Shakers of 2023

As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the…

Podcast 42: CDMO/CMO Mid-Year Review: Tracking the Key Moves Thus Far in 2023 

As we near the mid-year mark, what have been the key moves—mergers and acquisitions, expansions, and new CDMOs entering the market—thus far in 2023? DCAT Value Chain Insights takes an…

Podcast 41: API Alert: EU Proposes New Requirements To Secure Pharma Supply Chains 

The European Commission has issued its long-awaited proposal to reform pharmaceutical legislation in the EU, the first major overhaul in 20 years, which includes new requirements to address drug shortages…